Deep Brain Stimulation

A study of 10 people with Parkinson's disease and 10 healthy controls found differences in how brain activity varied across walking phases while patients were on medication and receiving deep brain stimulation at their usual clinical settings. Researchers simultaneously recorded EEG, subthalamic nucleus signals, and whole-body movement, analyzing only straight walking segments. Group differences were limited in averaged spectra, but step-by-step analysis revealed prominent high-beta and gamma timing differences and gait-cycle modulation in the subthalamic nucleus. These signals are not yet established biomarkers of impaired gait; their relationships with walking speed, stride length, and step-to-step variability still need testing. This study is a preprint and has not been peer reviewed.

A mini-review places deep-brain stimulation, brain-computer interfaces and speech neuroprostheses within a shared closed-loop architecture of sensing, decoding, stimulation or output, power, telemetry and chronic validation. It identifies long-term stability, neural coding and equitable access as recurring constraints across all three fields and argues that governance must advance alongside engineering.